Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32232419.
- Also identified by DOI 10.7326/M20-1334 and PMC identifier 7138336.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019. The authors of this commentary provide guidance for clinical decision making for patients with coronavirus disease 2019 as well as for patients with rheumatologic conditions, such as systemic lupus erythematosus and rheumatoid arthritis
Medical subject headings
- Chloroquine
- Coronavirus Infections
- Hydroxychloroquine
- Pneumonia, Viral
- Rheumatic Diseases